CYBB and glioblastoma: Moreover, the patients with high levels of NOX2 gene expression (median survival: 1062 days) had poor survival rates compared to patients with low levels of the NOX2 gene (median survival: 2282 days) in the analysis of the GBM and LGG datasets from TCGA (Figure 1e).